Ten-figure financings may be a rational response to the capital needs of AI, energy, space, and advanced manufacturing companies. However, capital raised is not the same as value created, and history shows how quickly enthusiasm can outpace fundamentals.
It seems that every few days brings another headline about a private company raising more than $1 billion:
Together, those five announcements represent more than $5.4 billion raised in less than two weeks.
The numbers confirm that this is more than a run of eye-catching headlines. In a July 23 report, Crunchbase found that U.S.-based startups had already closed 23 known rounds of at least $1 billion in 2026. That matched the total for all of 2025 and exceeded the 22 recorded during the venture boom of 2021. Several more followed almost immediately.
The concentration is even more striking. Crunchbase estimated that billion-dollar-plus rounds had absorbed approximately $320 billion, or 60% of global startup funding through the report date. In the U.S., they represented approximately $290 billion, or 73% of funding, with more than half going to just OpenAI and Anthropic. In July alone, 14 companies worldwide completed billion-dollar rounds, including 9 U.S.-based companies – the highest monthly count on record.
Clearly, something significant is happening in private markets. The pressing question is what it means.
The Case for Optimism
Venture capital has never been designed to distribute money evenly. Its returns typically come from a small number of exceptional companies, so concentration behind apparent winners is not necessarily a defect; it is often how the model works.
Many of today’s megadeals differ from the large financings of the software and consumer-internet boom. Investors are backing more capital-intensive companies building factories, energy assets, batteries, chips, data infrastructure and first-of-a-kind technical systems.
A billion-dollar round can therefore be rational when the capital is tied to measurable milestones, supported by credible demand and deployed into assets that create a durable advantage. It may give a company enough runway to complete a plant, prove a manufacturing process or deliver a complex system without repeatedly returning to the market.
The surge has also coincided with a strong exit environment. Crunchbase counted 32 venture-backed companies that went public at valuations above $1 billion in the second quarter of 2026, along with 24 acquisitions worth at least $1 billion. A functioning exit market makes late-stage investment more defensible than one sustained only by successive private rounds.
But Bigger Rounds do not Necessarily mean a Healthier Market
Record totals can create an illusion of breadth. North American venture dollars rose 190% year over year in the first quarter of 2026, according to Crunchbase, while the number of deals fell 26%. Far more money went into fewer companies.
For startups outside favored areas such as AI, space, defense and energy, the market may feel nothing like a boom. A healthy innovation ecosystem should be judged not only by the capital invested in its largest companies, but also by new-company formation, access to follow-on funding, investor diversity and realized returns.
Additionally, large rounds also create large expectations.
More capital may reduce the immediate risk of running out of cash, but it does not eliminate product, manufacturing, regulatory, customer-concentration or competitive risks. It can simply transform financing risk into terminal-value risk: the company survives but never becomes valuable enough to justify the price investors paid.
Capital is valuable partly because it gives companies time. That benefit can become a liability when time is mistaken for validation.
So, are Billion-Dollar Rounds Good or Bad?
Billion-dollar rounds are neither automatic evidence of a bubble nor proof of a healthy market. They show that investors are making larger, more concentrated bets on fewer, capital-intensive companies.
For businesses with validated technology, credible demand, and a clear relationship between spending and milestones, such financing can help create an enduring market leader. Some projects being funded today would be nearly impossible to complete with conventional venture-round sizes.
But capital is an accelerant: it magnifies mistakes as well as successes. When valuations move ahead of technical evidence or commercial adoption, more money can encourage premature expansion, weaken discipline, and create an exit hurdle that even a good company cannot clear. Heavy concentration also makes aggregate funding a poor measure of ecosystem health.
The current cycle may ultimately look less like the software exuberance of 2021 and more like an infrastructure investment supercycle. Building AI capacity, power generation, energy storage, and domestic manufacturing may genuinely require private companies to raise amounts once associated only with public corporations or governments.
Even so, capital is not proof, and the burden of proof should rise with the size of the check. Capital alone cannot create viable unit economics, eliminate manufacturing difficulties, compress regulatory timelines, or guarantee that future public investors will accept today’s private valuation.
The prudent response is therefore neither to dismiss every billion-dollar round as irrational nor to celebrate each one as validation. Some of today’s megadeal recipients will likely become defining companies of the next decade. Others may discover that a billion-dollar financing can postpone the market’s verdict, but it cannot prevent it.
DISCLOSURE: This material has been prepared or is distributed solely for informational purposes only and is not a solicitation or an offer to buy any security or instrument or to participate in any trading strategy. Any opinions, recommendations, and assumptions included in this presentation are based upon current market conditions, reflect our judgment as of the date of this presentation, and are subject to change. Past performance is no guarantee of future results. All investments involve risk including the loss of principal. All material presented is compiled from sources believed to be reliable, but accuracy cannot be guaranteed and Evergreen makes no representation as to its accuracy or completeness. Securities highlighted or discussed in this communication are mentioned for illustrative purposes only and are not a recommendation for these securities. Evergreen actively manages client portfolios and securities discussed in this communication may or may not be held in such portfolios at any given time.
